____This viral infection is characterized by the [very] acute onset of fever, chills, shaking,
muscle pain [notably backache], +/- nausea, cough with burning retrosternal pain.
____The #1 cause croup in children and laryngitis in adults and the second major cause of childhood
pneumonitis and lower respiratory tract infections
___ the route of transmission of HAV (and HEV)
___ influenza protein that alters the viscosity of mucin protein in mucus
____#1 cause of serious viral pneumonitis in premature infants and young children
and an important cause of bronchitis and viral middle ear infections.
___A vaccine that requires a new annual version to combat genetic drift of the virus
___This influenza virus has a very high fatality rate in humans, but is not transmissible H2H.
___A monoclonal antibody used to prevent RSV in premature infants
___Inhibits neuraminidase of influenza.
___ vaccine for "infectious" [enteric] hepatitis
___ Yearly epidemics of influenza are due to this
___ influenza protein that binds to the lung cell receptor protein
___The major cause of blindness in HIV+ patients
___Acute, enteroviral hepatitis, that is often subclinical in infants: in adults
and it causes fever, nausea, anorexia, and diarrhea, then jaundice.
___ common flu complications, often in elderly, and the cause of most flu-associated mortality
___Persistent hepatitis in 70-90% of all patients is due to this virus
___these viruses usually cause upper respiratory tract infections, and one strain caused a worldwide
pandemic 8 years ago, with significant mortality
___A mixture of NRTI’s and NNRTI’s, and protease inhibitors
___a common influenza type circulating from 1977 to today, and that appeared as a new 'shift'
in 2009. and the designation of the 1918 Spanish flu
___ reverse transcriptase inhibitors that resemble DNA or RNA precursors
___ standard therapy for food acquired hepatitis
___ HIV drug that inhibits fusion of viral and cell membranes
___The leading infectious cause of immune suppression in the world
___ patients that generally do not become jaundiced with HAV
___ routes of HIV transmission
___ these viruses transcribe viral RNA into DNA, and integrate the DNA into host DNA
___ genetic immunity to HIV is due mutations in this gene
___ major surface antigens of HIV
___ symptoms of HIV primary infection
___ HIV is characterized by these type of infections
___Hepatitis with an insidious onset; 95% infants acquire lifelong infection; 95% adults do not.
___ the vaccine for "transfusion" hepatitis
___An NRTI that works on both HIV and HBV
___The final phase of this viral infection is characterized by opportunistic infections with
protozoa, fungi, bacteria, and chronic reactivation of herpes viruses
___ reverse transcriptase inhibitors that do not resemble DNA or RNA precursors
___ the standard therapy for HCV
___ Pandemics of influenza are due to this, when a new H/N type appears from a zoonotic reservoir
___ the route of transmission of HBV and HCV
___ patients that are generally icteric due to HAV
A AIDS
B bacterial pneumonia
C blood transfusion; needles (IVDU and tattoo)
D CCR5 co-receptor
E CMV retinitis
F corona viruses
G Fuseon
H fecal-oral
I gamma globulin
J genetic shift
K genetic drift
L HAART
M hemagglutinin
N H1N1
O H5N1
P HIV
Q HAV
R HAV inactivated vaccine
S HBV
T HBV subunit vaccine
U HCV
V inactivated influenza A vaccine
W infants
X influenza A
Y Lamivudine = “Epivir”
Z lymphadenopathy, retroviral rash, sore throat
AA NNRTI
BB NRTI
CC neuraminidase
DD older children/teens and all adults
EE opportunistic
FF parainfluenza viruses
GG p120 and p41envelope proteins
HH respiratory syncitial virus
II retroviruses
JJ ribivarin and interferon
KK Synagis
LL Tamiflu
MM sex, transfusion, IVDU, transplacental,
vaginal birth, and breast feeding